207 related articles for article (PubMed ID: 21242173)
1. Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial.
Duda C; Mahon I; Chen MH; Snyder B; Barr R; Chiles C; Falk R; Fishman EK; Gemmel D; Goldin JG; Brown K; Munden RF; Vydareny K; Aberle DR
Clin Trials; 2011 Apr; 8(2):214-23. PubMed ID: 21242173
[TBL] [Abstract][Full Text] [Related]
2. Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial.
Dew A; Khan S; Babinski C; Michel N; Heffernan M; Stephan S; Jordan N; Jovanovic B; Carney P; Bergan R
Clin Trials; 2013 Apr; 10(2):292-9. PubMed ID: 23321266
[TBL] [Abstract][Full Text] [Related]
3. Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination.
Fitch KV; Kileel EM; Looby SE; Zanni MV; Sanchez LR; Fichtenbaum CJ; Overton ET; Malvestutto C; Aberg JA; Klingman KL; Alston-Smith B; Lavelle J; Rancourt A; Badal-Faesen S; Cardoso SW; Avihingsanon A; Patil S; Sponseller CA; Melbourne K; Ribaudo HJ; Cooper-Arnold K; Desvigne-Nickens P; Hoffmann U; Douglas PS; Grinspoon SK;
HIV Res Clin Pract; 2020 Feb; 21(1):11-23. PubMed ID: 32160827
[No Abstract] [Full Text] [Related]
4. Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Pinsky PF; Ford M; Gamito E; Higgins D; Jenkins V; Lamerato L; Tenorio S; Marcus PM; Gohagan JK
J Natl Med Assoc; 2008 Mar; 100(3):291-8. PubMed ID: 18390022
[TBL] [Abstract][Full Text] [Related]
5. National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communities.
McCaskill-Stevens W; Wilson JW; Cook ED; Edwards CL; Gibson RV; McElwain DL; Figueroa-Moseley CD; Paskett ED; Roberson NL; Wickerham DL; Wolmark N
Clin Trials; 2013 Apr; 10(2):280-91. PubMed ID: 23335675
[TBL] [Abstract][Full Text] [Related]
6. Recruitment and Retention Strategies Among Racial and Ethnic Minorities in Web-Based Intervention Trials: Retrospective Qualitative Analysis.
Hwang DA; Lee A; Song JM; Han HR
J Med Internet Res; 2021 Jul; 23(7):e23959. PubMed ID: 34255658
[TBL] [Abstract][Full Text] [Related]
7. Successful Strategies for Practice-Based Recruitment of Racial and Ethnic Minority Pregnant Women in a Randomized Controlled Trial: the IDEAS for a Healthy Baby Study.
Goff SL; Youssef Y; Pekow PS; White KO; Guhn-Knight H; Lagu T; Mazor KM; Lindenauer PK
J Racial Ethn Health Disparities; 2016 Dec; 3(4):731-737. PubMed ID: 27068662
[TBL] [Abstract][Full Text] [Related]
8. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
[TBL] [Abstract][Full Text] [Related]
9. Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Gren L; Broski K; Childs J; Cordes J; Engelhard D; Gahagan B; Gamito E; Gardner V; Geisser M; Higgins D; Jenkins V; Lamerato L; Lappe K; Lowery H; McGuire C; Miedzinski M; Ogden S; Tenorio S; Watt G; Wohlers B; Marcus P
Clin Trials; 2009 Feb; 6(1):52-9. PubMed ID: 19254935
[TBL] [Abstract][Full Text] [Related]
10. The Diabetes Prevention Program: recruitment methods and results.
Rubin RR; Fujimoto WY; Marrero DG; Brenneman T; Charleston JB; Edelstein SL; Fisher EB; Jordan R; Knowler WC; Lichterman LC; Prince M; Rowe PM;
Control Clin Trials; 2002 Apr; 23(2):157-71. PubMed ID: 11943442
[TBL] [Abstract][Full Text] [Related]
11. Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial.
Gohagan JK; Broski K; Gren LH; Fouad MN; Higgins D; Lappe K; Ogden S; Shambaugh V; Pinsky PF; O'Brien B; Yurgalevich S; Riley T; Wright P; Prorok PC
Rev Recent Clin Trials; 2015; 10(3):187-93. PubMed ID: 26435288
[TBL] [Abstract][Full Text] [Related]
12. Design of a cluster-randomized minority recruitment trial: RECRUIT.
Tilley BC; Mainous AG; Smith DW; McKee MD; Amorrortu RP; Alvidrez J; Diaz V; Ford ME; Fernandez ME; Hauser RA; Singer C; Landa V; Trevino A; DeSantis SM; Zhang Y; Daniels E; Tabor D; Vernon SW
Clin Trials; 2017 Jun; 14(3):286-298. PubMed ID: 28545336
[TBL] [Abstract][Full Text] [Related]
13. Does study subject diversity influence cardiology research site performance?: Insights from 2 U.S. National Coronary Stent Registries.
Batchelor WB; Damluji AA; Yong C; Fiuzat M; Barnett SD; Kandzari DE; Sherwood MW; Epps KC; Tehrani BN; Allocco DJ; Meredith IT; Lindenfeld J; O'Connor CM; Mehran R
Am Heart J; 2021 Jun; 236():37-48. PubMed ID: 33636137
[TBL] [Abstract][Full Text] [Related]
14. Is Our Science Representative? A Systematic Review of Racial and Ethnic Diversity in Orthopaedic Clinical Trials from 2000 to 2020.
Cwalina TB; Jella TK; Manyak GA; Kuo A; Kamath AF
Clin Orthop Relat Res; 2022 May; 480(5):848-858. PubMed ID: 34855650
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement.
Hawk ET; Habermann EB; Ford JG; Wenzel JA; Brahmer JR; Chen MS; Jones LA; Hurd TC; Rogers LM; Nguyen LH; Ahluwalia JS; Fouad M; Vickers SM
Cancer; 2014 Apr; 120 Suppl 7(0 7):1113-21. PubMed ID: 24643649
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Racial, Ethnic, and Geographic Location Diversity of Participants Enrolled in Clinic-Based vs 2 Remote COVID-19 Clinical Trials.
Stewart J; Krows ML; Schaafsma TT; Heller KB; Brown ER; Boonyaratanakornkit J; Brown CE; Leingang H; Liou C; Bershteyn A; Schwartz MD; Agrawal V; Friedman-Klabanoff D; Eustace S; Stankiewicz Karita HC; Paasche-Orlow MK; Kissinger P; Hosek SG; Chu HY; Celum C; Baeten JM; Wald A; Johnston C; Barnabas RV
JAMA Netw Open; 2022 Feb; 5(2):e2148325. PubMed ID: 35157053
[TBL] [Abstract][Full Text] [Related]
18. Comparing the Efficiency of Online and Field-Based Outreach for the Recruitment of Black and Latino Sexual Minority Men into an HIV Prevention Implementation Trial.
Bradford-Rogers J; Lopez-Matos J; Cain D; Lopez D; Starks TJ
Prev Sci; 2022 Aug; 23(6):900-906. PubMed ID: 35394598
[TBL] [Abstract][Full Text] [Related]
19. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
20. Interventions to increase racial and ethnic minority accrual into cancer clinical trials: A systematic review.
Nouvini R; Parker PA; Malling CD; Godwin K; Costas-Muñiz R
Cancer; 2022 Nov; 128(21):3860-3869. PubMed ID: 36107740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
